Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
Editor’s note: This is a developing news story. Please check back soon for updates.
In a pivotal clinical trial, an excimer laser procedure reduced IOP in patients with glaucoma, according to a press release from Bausch + Lomb.
The Elios system reduced patients’ IOP by creating microchannels in the trabecular meshwork to improve aqueous flow.
Researchers conducted a prospective study including 318 patients at 20 U.S. sites who were previously diagnosed with mild to moderate primary open-angle glaucoma, for which they were taking glaucoma medications, and cataracts. The co-primary endpoints